BSE filing, NSE: SANJIVIN. Summary written from the filing by ALFA Finder's alert engine.
Sanjivani Paranteral Ltd: key numbers
- Share price
- ₹168.40
- Market cap
- ₹206.9 Cr
- Revenue (annual)
- ₹68.67 Cr
- Net profit (annual)
- ₹6.79 Cr
- P/E (TTM)
- 19.6×Sector 48.7×
- Promoter holding
- 31.56%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanjivani Paranteral Ltd
All →Sanjivani Paranteral Board Meeting Date
Sanjivani Paranteral will hold a board meeting on 5 November 2026 to approve Q2 unaudited results. The agenda is only proposed until the meeting is held.
Sanjivani Paranteral Other Announcement
Sanjivani Paranteral Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI listing regulations.
Sanjivani Paranteral Fund Raise
Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.
Sanjivani Paranteral Annual General Meeting
Sanjivani Paranteral Limited held its 32nd Annual General Meeting on September 16, 2026. The meeting concluded with resolutions on financial statements and director re-appointment.
Sanjivani Paranteral Annual Report
Sanjivani Paranteral Limited has filed its Annual Report for the financial year 2025-26 as required under SEBI regulations. The document details the company's annual performance.
Sanjivani Paranteral Annual General Meeting
Sanjivani Paranteral shareholders approved the issuance of 5,00,000 convertible warrants to promoters on a preferential basis. A material related party transaction with subsidiary SPL Infusion was also cleared.
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.